Androgen Receptor Protein Degrader Manufacturing for High Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing the androgen receptor protein degrader Compound A face challenges in achieving high purity and efficiency, particularly in controlling impurities and ensuring consistent product quality.
Innovation Solution
A multi-step synthetic process involving specific molar ratios, solvent choices, and temperature controls is employed, including reductive amination, acid treatment, and coupling reactions with precise additives to produce Compound A in crystalline or amorphous forms with purities greater than 95%.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing synthesis methods are used, then production can be achieved, but product purity and consistency are insufficient
Solution Approach 1:
The synthesis process is divided into discrete, optimized steps with specific intermediates (I-1 through I-4) and controlled transformations. Each step is independently optimized with defined reagents, conditions, and purification methods, allowing precise control over product purity while maintaining manufacturability through systematic process breakdown.
Solution Approach 2:
The patent employs systematic variation of synthesis parameters including solvent types (DCM, MeCN, EtOAc), temperatures (0°C to room temperature), reagent ratios (1.1-2.0 equivalents), and purification conditions to optimize product purity. These parameter changes enable consistent high-purity production while providing clear guidance for manufacturing.
2Manufacturing precision
If high purity is achieved through multiple purification steps, then product quality improves, but production time and complexity increase
Solution Approach 1:
The synthesis route is designed with preliminary purification actions embedded in each step, including filtration through silica gel, washing with specific solvents, and controlled drying conditions. These preliminary actions prevent impurity accumulation and reduce the need for extensive final purification, thereby maintaining high purity while minimizing overall production time.
Solution Approach 2:
The patent maintains continuous productive action by optimizing each synthesis step to proceed efficiently with minimal idle time. Reactions are conducted under conditions that maximize conversion and minimize side products, and purification steps are streamlined to quickly remove impurities without requiring prolonged processing, thus maintaining high purity without excessive time loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high-purity Compound A with reduced impurities, enhancing product consistency and quality, suitable for pharmaceutical applications.
Implementation Method 1
reacting Intermediate I-1 with Intermediate I-2 or a salt thereof, in a reaction mixture, wherein the reaction mixture comprises a base, a reducing agent, and a solvent to provide wet Intermediate I-3
Implementation Method 2
reacting Intermediate I-3 or a salt thereof, with an acid in a reaction mixture to provide Intermediate I-4 or a salt thereof
Data Source
AI summary
This disclosure pertains to methods of manufacturing Compound A and intermediates in the preparation of Compound A, including methods for the preparation and purification of Compound A, and preparation and purification of such intermediates.